| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INDIRECT ACCOUNTING FEES | 540 | 270 | 270 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| AT&T | 2012-03 | PURCHASE | 2017-12 | 19,440 | 15,849 | 3,591 | ||||
| GLAXO SMITHKLINE PLC ADR | 2012-03 | PURCHASE | 2017-12 | 11,356 | 14,797 | -3,441 | ||||
| EVERGY INC | 2001-01 | PURCHASE | 2018-06 | 27 | 24 | 3 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| UBS | 187,715 | 342,807 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| UBS ADVISORY FEES | 3 | 3 | ||
| INCIDENTAL EXPENSES | 197 | 197 |
| Description | Amount |
|---|---|
| RETURN OF CAPITAL | 394 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INDIRECT TAXES/LICENSES | 243 | 120 |